DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Net Block History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Block | ₹5,442 Cr | ₹4,739 Cr | ₹4,722 Cr | ₹4,325 Cr | ₹3,704 Cr |
What is the latest Net Block ratio of DIVIS LABORATORIES ?
| Year | Net Block |
|---|---|
| Mar2025 | ₹5,442 Cr |
| Mar2024 | ₹4,739 Cr |
| Mar2023 | ₹4,722 Cr |
| Mar2022 | ₹4,325 Cr |
| Mar2021 | ₹3,704 Cr |
How is Net Block of DIVIS LABORATORIES Trending?
| Years | Net Block | % Change | |
|---|---|---|---|
| Mar2025 | ₹5,442 Cr | 14.83 | |
| Mar2024 | ₹4,739 Cr | 0.36 | |
| Mar2023 | ₹4,722 Cr | 9.18 | |
| Mar2022 | ₹4,325 Cr | 16.77 | |
| Mar2021 | ₹3,704 Cr | - | |
Compare Net Block of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹155,503.4 Cr | -2.6% | -8.7% | 1.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,603.0 Cr | -5.6% | -2.5% | -1.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,009.0 Cr | -7.2% | -8% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,628.0 Cr | -6.5% | -5.4% | 3.9% | Stock Analytics | |
| CIPLA | ₹96,400.8 Cr | -4.1% | -11.5% | -19% | Stock Analytics | |
| MANKIND PHARMA | ₹82,460.4 Cr | -1.1% | -11.1% | -16.9% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -2.6% |
-8.7% |
1.2% |
| SENSEX | -1% |
-10.9% |
-6% |
You may also like the below Video Courses